“The passage rates of huperzine A were increased significantly with adding different concentrations of ginkgolide B. CONCLUSIONS The compound preparations of HA in combination with GB for dementia caused by cerebral ischemic have synergistic effects on the pharmacodynamics, and improve the bioavailability through BBB.”